AbbVie Inc.
United States
Lutikizumab
Under development
Finished product (FDF)
Verified on 2026-10-21
Lutikizumab + Ravagalimab
Under development
Finished product (FDF)
Verified on 2026-10-21
Risankizumab + Lutikizumab
Under development
Finished product (FDF)
Verified on 2026-10-21